EUVIMEDEUVIMED entdecken
Crossref

Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease

Richa Mehta, Salini Nair, Sahyadri Manjunath, Santhepete Nanjundaiah Manjula, Gokul Ramesh, Sathish Kumar Gunasekaran, Mamatha Gavisiddaiah, Prashant Yuvaraj Mali

Pharmacognosy Reviews · 03.08.2026 · 20 (40) · 154-169

DOI: 10.5530/phrev.20260004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacognosy Reviews, online erschienen am 03.08.2026. Verfasst von Richa Mehta und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mehta, R., Nair, S., Manjunath, S., Manjula, S. N., Ramesh, G., Gunasekaran, S. K., Gavisiddaiah, M., & Mali, P. Y. (2026). Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease. Pharmacognosy Reviews, 20(40), 154-169. https://doi.org/10.5530/phrev.20260004

Vancouver

Mehta R, Nair S, Manjunath S, Manjula SN, Ramesh G, Gunasekaran SK, et al. Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease. Pharmacognosy Reviews. 2026;20(40):154-169. doi:10.5530/phrev.20260004

BibTeX
@article{Mehta2026,
  author = {Mehta, Richa and Nair, Salini and Manjunath, Sahyadri and Manjula, Santhepete Nanjundaiah and Ramesh, Gokul and Gunasekaran, Sathish Kumar and Gavisiddaiah, Mamatha and Mali, Prashant Yuvaraj},
  title = {Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease},
  journal = {Pharmacognosy Reviews},
  year = {2026},
  volume = {20},
  number = {40},
  pages = {154--169},
  doi = {10.5530/phrev.20260004}
}
Kostenlos starten →